| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 659856 | 69265 | METOCLOPRAMIDA PENSA 1 mg/ml SOLUCION ORAL EFG | METOCLOPRAMIDA PENSA 1 mg/ml SOLUCION ORAL EFG, 1 frasco de 250 ml | 1 mg/ml | 6 | 250 | 26 | 1 frasco de 250 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69265/69265_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69265/69265_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | TOWA PHARMACEUTICAL S.A. | 2007-09-19 | 1 | 1 | 1 | 2007-09-19 | 2007-09-19 | 1 | 2011-06-16 | View Edit Delete | ||||||||||||
| 658697 | 06379001 | CYSTADANE 1 g POLVO ORAL | CYSTADANE 1 g POLVO ORAL , 1 frasco de 180 g + 3 cucharas graduadas | 1 g/g | 6 | 180 | 21 | 1 frasco de 180 g + 3 cucharas graduadas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/06379001/06379001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/06379001/06379001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 68204 | RECORDATI RARE DISEASES SPAIN, S.L.U. | 2007-04-25 | 1 | 1 | 1 | 2007-04-25 | 2007-04-25 | 0 | 2011-05-10 | View Edit Delete | ||||||||||||
| 659610 | 69135 | TOPIRAMATO CINFA 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | TOPIRAMATO CINFA 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 60 comprimidos (FRASCO) | 25 mg | 6 | 60 | 10 | 60 comprimidos (FRASCO) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69135/69135_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69135/69135_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2007-07-23 | 1 | 1 | 1 | 2007-07-23 | 2007-07-23 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 659612 | 69136 | TOPIRAMATO CINFA 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | TOPIRAMATO CINFA 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 60 comprimidos (FRASCO) | 50 mg | 6 | 60 | 10 | 60 comprimidos (FRASCO) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69136/69136_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69136/69136_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2007-07-23 | 1 | 1 | 1 | 2007-07-23 | 2007-07-23 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 659618 | 69137 | TOPIRAMATO CINFA 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | TOPIRAMATO CINFA 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 60 comprimidos (FRASCO) | 100 mg | 6 | 60 | 10 | 60 comprimidos (FRASCO) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69137/69137_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69137/69137_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2007-07-23 | 1 | 1 | 1 | 2007-07-23 | 2007-07-23 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 659620 | 69138 | TOPIRAMATO CINFA 200 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | TOPIRAMATO CINFA 200 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 60 comprimidos (FRASCO) | 200 mg | 6 | 60 | 10 | 60 comprimidos (FRASCO) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69138/69138_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69138/69138_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2007-07-23 | 1 | 1 | 1 | 2007-07-23 | 2007-07-23 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 659767 | 69214 | CINFAMUCOL CARBOCISTEINA 50 mg/ml SOLUCION ORAL | CINFAMUCOL CARBOCISTEINA 50 mg/ml SOLUCION ORAL , 1 frasco de 200 ml | 50 mg/ml | 6 | 200 | 26 | 1 frasco de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69214/69214_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69214/69214_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2007-08-08 | 1 | 1 | 1 | 2007-08-08 | 2007-08-08 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 658831 | 62133 | ZINERYT 40 MG/ML + 12 MG/ML POLVO Y DISOLVENTE PARA SOLUCIÓN CUTÁNEA | ZINERYT 40 MG/ML + 12 MG/ML POLVO Y DISOLVENTE PARA SOLUCIÓN CUTÁNEA , 1 frasco de 30 ml | 40 mg/ml + 12 mg/ml | 6 | 30 | 26 | 1 frasco de 30 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62133/62133_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62133/62133_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 25535 | LABORATORIOS RUBIO S.A. | 1999-06-01 | 1 | 1 | 1 | 1999-06-01 | 1999-06-01 | 1 | 2011-10-26 | View Edit Delete | ||||||||||||
| 660113 | 03268004 | CHOLESTAGEL 625 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | CHOLESTAGEL 625 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 180 comprimidos | 625 mg | 6 | 180 | 10 | 180 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/03268004/03268004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/03268004/03268004_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 25535 | LABORATORIOS RUBIO S.A. | 2008-03-25 | 1 | 1 | 1 | 2008-03-25 | 2008-03-25 | 1 | 2011-09-06 | View Edit Delete | ||||||||||||
| 658860 | 68681 | TOPIRAMATO KERN PHARMA 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | TOPIRAMATO KERN PHARMA 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 60 comprimidos | 25 mg | 6 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68681/68681_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68681/68681_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2007-04-25 | 1 | 1 | 1 | 2007-04-25 | 2007-04-25 | 1 | 2011-10-17 | View Edit Delete | ||||||||||||
| 658861 | 68682 | TOPIRAMATO KERN PHARMA 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | TOPIRAMATO KERN PHARMA 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 60 comprimidos | 50 mg | 6 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68682/68682_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68682/68682_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2007-04-25 | 1 | 1 | 1 | 2007-04-25 | 2007-04-25 | 1 | 2011-10-17 | View Edit Delete | ||||||||||||
| 658862 | 68683 | TOPIRAMATO KERN PHARMA 200 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | TOPIRAMATO KERN PHARMA 200 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 60 comprimidos | 200 mg | 6 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68683/68683_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68683/68683_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2007-04-25 | 1 | 1 | 1 | 2007-04-25 | 2007-04-25 | 1 | 2011-10-17 | View Edit Delete | ||||||||||||
| 658916 | 68723 | TOPIRAMATO KERN PHARMA 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | TOPIRAMATO KERN PHARMA 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 60 comprimidos | 100 mg | 6 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68723/68723_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68723/68723_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2007-04-25 | 1 | 1 | 1 | 2007-04-25 | 2007-04-25 | 1 | 2011-10-17 | View Edit Delete | ||||||||||||
| 659070 | 68806 | RISPERIDONA KERN PHARMA 1 mg/ml SOLUCION ORAL EFG | RISPERIDONA KERN PHARMA 1 mg/ml SOLUCION ORAL EFG , 1 frasco de 30 ml | 1 mg/ml | 6 | 30 | 26 | 1 frasco de 30 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68806/68806_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68806/68806_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2007-05-22 | 1 | 1 | 1 | 2007-05-22 | 2007-05-22 | 1 | 2011-10-17 | View Edit Delete | ||||||||||||
| 659071 | 68806 | RISPERIDONA KERN PHARMA 1 mg/ml SOLUCION ORAL EFG | RISPERIDONA KERN PHARMA 1 mg/ml SOLUCION ORAL EFG , 1 frasco de 100 ml | 1 mg/ml | 6 | 100 | 26 | 1 frasco de 100 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68806/68806_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68806/68806_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2007-05-22 | 1 | 1 | 1 | 2007-05-22 | 2007-05-22 | 1 | 2011-10-17 | View Edit Delete | ||||||||||||
| 659857 | 69266 | METOCLOPRAMIDA KERN PHARMA 1 mg/ml SOLUCION ORAL EFG | METOCLOPRAMIDA KERN PHARMA 1 mg/ml SOLUCION ORAL EFG, 1 frasco de 250 ml | 1 mg/ml | 6 | 250 | 26 | 1 frasco de 250 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69266/69266_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69266/69266_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2007-09-19 | 1 | 1 | 1 | 2007-09-19 | 2007-09-19 | 1 | 2011-10-17 | View Edit Delete | ||||||||||||
| 660172 | 69429 | PARACETAMOL KERN PHARMA 100 mg/ml SOLUCION ORAL EFG | PARACETAMOL KERN PHARMA 100 mg/ml SOLUCION ORAL EFG , 1 frasco de 30 ml | 100 mg/ml | 6 | 30 | 26 | 1 frasco de 30 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69429/69429_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69429/69429_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2007-11-30 | 1 | 1 | 1 | 2007-11-30 | 2007-11-30 | 1 | 2011-02-16 | View Edit Delete | ||||||||||||
| 660173 | 69429 | PARACETAMOL KERN PHARMA 100 mg/ml SOLUCION ORAL EFG | PARACETAMOL KERN PHARMA 100 mg/ml SOLUCION ORAL EFG, 1 frasco de 60 ml | 100 mg/ml | 6 | 60 | 26 | 1 frasco de 60 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69429/69429_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69429/69429_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2007-11-30 | 1 | 1 | 1 | 2007-11-30 | 2007-11-30 | 1 | 2011-02-16 | View Edit Delete | ||||||||||||
| 659711 | 69188 | LANSOPRAZOL VIR 15 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | LANSOPRAZOL VIR 15 mg CAPSULAS DURAS GASTRORRESISTENTES EFG, 28 cápsulas | 15 mg | 6 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69188/69188_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69188/69188_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3050 | INDUSTRIA QUIMICA Y FARMACEUTICA VIR S.A. | 2007-07-30 | 1 | 1 | 1 | 2007-07-30 | 2007-07-30 | 1 | 2011-06-08 | View Edit Delete | ||||||||||||
| 659712 | 69189 | LANSOPRAZOL VIR 30 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | LANSOPRAZOL VIR 30 mg CAPSULAS DURAS GASTRORRESISTENTES EFG, 14 cápsulas | 30 mg | 6 | 14 | 43 | 14 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69189/69189_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69189/69189_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3050 | INDUSTRIA QUIMICA Y FARMACEUTICA VIR S.A. | 2007-07-30 | 1 | 1 | 1 | 2007-07-30 | 2007-07-30 | 1 | 2014-06-14 | View Edit Delete |
Page 151 of 1035, showing 20 records out of 20684 total, starting on record 3001, ending on 3020